TA
TECH icon

Tiedemann Advisors’s Bio-Techne TECH Stock Holding History

Tiedemann Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,800
Closed -$203K – 361
2021
Q2 		$203K Buy
+1,800
New +$189K 0.01% 346
2017
Q4 		– Sell
-16,312
Closed -$447K – 324
2017
Q3 		$447K Buy
+16,312
New +$484K 0.04% 231
2017
Q1 		– Sell
-18,352
Closed -$472K – 418
2016
Q4 		$472K Buy
+18,352
New +$482K 0.05% 217

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Tiedemann Advisors's TECH Position: Q3 2021 in Review

Tiedemann Advisors sold out of Bio-Techne (TECH) in Q3 2021, closing a stake of 1,800 shares — an estimated $203K sold.

Tiedemann Advisors first reported a position in TECH in Q4 2016 and held it in 3 quarters. The position peaked at $472K in Q4 2016. 565 funds tracked by Wall St. Rank hold TECH as of Q3 2021.

  • Tiedemann Advisors reported no remaining Bio-Techne position as of Q3 2021 after selling out during the quarter.
  • Tiedemann Advisors sold 1,800 Bio-Techne shares in Q3 2021, an estimated $203K.
  • Tiedemann Advisors first reported a position in Bio-Techne in Q4 2016 and held it in 3 quarters.
  • Tiedemann Advisors's Bio-Techne position peaked at $472K in Q4 2016.
  • 565 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2021.

Based on Tiedemann Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.